Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: A multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study

Publication | Closed Access

DOI

Citations

References

2010

Year

Gavin R. Graff, Karen Maguiness, John McNamara, Ronald Morton, David Boyd, Katrin Beckmann, D. Bennett

Clinical Therapeutics

New FormulationPancrelipase Delayed-release CapsulesGastroenterologyPediatricsPediatric GastroenterologyPancreatic SurgeryPancreas TransplantationMedicine